Data / Form D filings / Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc.: Form D filings
Scorpion Therapeutics, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on July 16, 2024, reports $125.7 million sold of a $150 million offering to 38 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 Winthrop Square, Suite 400, Boston, MA, 02110
- Phone
- (781) 288-5760
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1811858
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | New notice | $150,000,002 | $125,694,186 | $24,305,816 | 38 | Jul 1, 2024 | sec.gov |
| Dec 7, 2020 | New notice | Indefinite | $146,999,977 | 22 | Nov 20, 2020 | sec.gov | |
| May 19, 2020 | New notice | Indefinite | $24,681,250 | 11 | Apr 23, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Fedder | Executive Officer | |
| Oleg Nodelman | Director | |
| Otello Stampacchia | Director | |
| Adam Friedman | Executive Officer, Director | |
| Shelley Chu | Director | |
| Darrin Stuart | Executive Officer | |
| Erica Jackson | Executive Officer | |
| Jean-Francois Formela | Director | |
| Amanda Valentino | Executive Officer | |
| Jeffrey Albers | Director | |
| Saurabh Saha | Director | |
| Arjun Goyal | Director | |
| Keith Flaherty | Director | |
| Mark Chao | Executive Officer | |
| Brian Piper | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 15, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Scorpion Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.